Biologics

Orthobiologics company Ossio closed a $38.5 million series C financing round.

Here are six key updates in regenerative medicine since Oct. 1:

Orthofix launched its Legacy demineralized bone matrix, and Alan Daniels, MD, performed the first case with it.

ChitogenX launched its second orthopedic development program in meniscus repair, the orthobiologics company said Oct. 13.

Aziyo Biologics promoted leadership and added new hires on its team, the company said Oct. 11.

Westminster, Colo.-based orthobiologics company Cerapedics has appointed Valeska Schroeder as its new CEO, effective Nov. 1. 

Three babies have been born after UC Davis Health providers performed the first spina bifida treatment combining surgery with stem cells.

Bone Biologics, which focuses on spinal orthobiologics, announced its underwritten public offering for $5.1 million total.

Precision Spine and HippoFi inked an agreement to help drive the sales of Pur Biologics products.

Pensacola, Fla.-based Andrews Medicine, led by James Andrews, MD, is partnering with Houston-based Celltex Therapeutics to form a biotechnology company focused on stem cell research and sports medicine.